Immuneering
4 articles with Immuneering
-
Immuneering Expands Leadership Team with Appointment of Carolina Garcia Rizo, Ph.D., MBA, as Chief Business OfficerGlobal business development leader joins executive team to contribute to Immuneering’s growth
3/25/2021
Immuneering Corporation today announced Carolina Garcia Rizo, Ph.D., MBA, has joined the company as chief business officer. Dr. Rizo brings to Immuneering extensive experience in the biotech and pharmaceutical industries, including senior-level leadership roles in global business development and strategy, machine learning (ML) based product development and commercial operations.
-
BioSpace is proud to present its NextGen Bio “Class of 2021,” a list of up-and-coming life sciences companies in North America that recently launched.
-
Immuneering Completes Oversubscribed $62 Million Series B Financing
1/5/2021
Financing to support advancement of Immuneering’s lead drug programs targeting cancers driven by alterations in the RAS/MAPK pathway and pipeline development of earlier programs in neuroscience and immuno-oncology
-
Ben Zeskind, chief executive officer of Immuneering, spoke with BioSpace following the annual J.P. Morgan Healthcare conference in San Francisco.